During the past decade, Sutter Cancer Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 37 clinical trials were completed, i.e. on average, 411.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Cancer Center" #1 sponsor was "Children's Oncology Group" with 48 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "NSABP Foundation Inc" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 79 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator and "Breast International Group" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Cancer Center" are "Leukemia" (21 trials), "Breast Cancer" (16 trials), "Lymphoma" (8 trials), "Sarcoma" (8 trials) and "Neuroblastoma" (7 trials). Many other conditions were trialed in "Sutter Cancer Center" in a lesser frequency.

Most popular intervention types in "Sutter Cancer Center" are "Drug" (90 trials), "Biological" (38 trials), "Radiation" (26 trials), "Procedure" (23 trials) and "Other" (11 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (33 trials), "etoposide" (25 trials), "radiation therapy" (23 trials), "filgrastim" (21 trials) and "vincristine sulfate" (20 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Cancer Center" are 92 trials for "All" genders, 13 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Sutter Cancer Center". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 90 completed trials in Sutter Cancer Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Cancer Center, 6 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".